E
ISPY2 trial plan

On neratinib in neoadjuvant breast cancer

Puma Biotech are expected to present the neoadjuvant data from ISPY2 for their pan HER inhibitor, neratinib, so what's the deal?

March 14, 2014
E
south pointe

MBCC: Will NGS change the way we treat metastatic breast cancer?

Dr Debu Tripathy presented one of the highlights of the MBCC conference - how we can use genomics to improve clinical trials in TNBC and MBC.

March 13, 2014
E
MBCC14

MBCC: Changing the way we approach advanced breast cancer

Can therapy for advanced breast cancer be individualized using proteomics and genomics data?

March 12, 2014